Skip to main content
PTPI logo

PTPI · Petros Pharmaceuticals, Inc.

Track PTPI — free
$0.05 -0.02 (-28.79%) At close · May 22
Market Cap
$169,489
Shares
42.37M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2023
Executive Total
Fady Boctor $875,096
Mitchell Arnold $488,253
Fiscal 2022
Executive Total
Fady Boctor $682,209
Mitchell Arnold $407,014
Andrew Gesek $135,796
Fiscal 2021
Executive Total
Fady Boctor $1,177,821
Andrew Gesek $545,388
Mitchell Arnold $497,584
Fiscal 2020
Executive Total
Fady Boctor $467,850
Keith Lavan $462,458
Andrew Gesek $407,423
Mitchell Arnold $354,634
Greg Ford $252,700
Fiscal 2019
Executive Total
Andrew Gesek $604,937
Greg Ford $450,399
Keith Lavan $413,302
Fady Boctor $339,745
Key facts CIK 1815903 CUSIP 71678J308 Visit website Investor relations